Search Browse Earnings

Vaxxinity, Inc.

OTC:VAXX

Pharmaceutical Preparations·EXPLORATION PARK, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Vaxxinity, Inc. — SlamSEC

Revenue

$66,000

-88.2% YoY

FY 2022

Adj. EBITDA

-$74.3M

-112568.2% margin

FY 2023

Net Income

-$75.2M

-113972.7% margin

FY 2023

EPS (Diluted)

-$0.60

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$33.5M

FY 2023

Total Debt

—

Net Cash

$33.5M

FY 2022

Enterprise Value

—

Debt / EBITDA

0.5x

FY 2022

EV / EBITDA

—

Employees

—